List of Tables
Table 1. Global Long-acting Antipsychotic Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Long-acting Antipsychotic Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Long-acting Antipsychotic Market Competitive Situation by Manufacturers in 2025
Table 4. Global Long-acting Antipsychotic Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Long-acting Antipsychotic Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Long-acting Antipsychotic Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Long-acting Antipsychotic Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Long-acting Antipsychotic Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Long-acting Antipsychotic, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Long-acting Antipsychotic, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Long-acting Antipsychotic, Product Types and Applications
Table 12. Global Key Manufacturers of Long-acting Antipsychotic, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting Antipsychotic Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-acting Antipsychotic Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting Antipsychotic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Long-acting Antipsychotic Sales by Region (K Units), 2021–2026
Table 18. Global Long-acting Antipsychotic Sales Market Share by Region (2021–2026)
Table 19. Global Long-acting Antipsychotic Sales by Region (K Units), 2027–2032
Table 20. Global Long-acting Antipsychotic Sales Market Share by Region (2027–2032)
Table 21. Global Long-acting Antipsychotic Revenue by Region (US$ Million), 2021–2026
Table 22. Global Long-acting Antipsychotic Revenue Market Share by Region (2021–2026)
Table 23. Global Long-acting Antipsychotic Revenue by Region (US$ Million), 2027–2032
Table 24. Global Long-acting Antipsychotic Revenue Market Share by Region (2027–2032)
Table 25. North America Long-acting Antipsychotic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Long-acting Antipsychotic Sales by Country (K Units), 2021–2026
Table 27. North America Long-acting Antipsychotic Sales by Country (K Units), 2027–2032
Table 28. North America Long-acting Antipsychotic Revenue by Country (US$ Million), 2021–2026
Table 29. North America Long-acting Antipsychotic Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Long-acting Antipsychotic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Long-acting Antipsychotic Sales by Country (K Units), 2021–2026
Table 32. Europe Long-acting Antipsychotic Sales by Country (K Units), 2027–2032
Table 33. Europe Long-acting Antipsychotic Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Long-acting Antipsychotic Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Long-acting Antipsychotic Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Long-acting Antipsychotic Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Long-acting Antipsychotic Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Long-acting Antipsychotic Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Long-acting Antipsychotic Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Long-acting Antipsychotic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Long-acting Antipsychotic Sales by Country (K Units), 2021–2026
Table 42. Latin America Long-acting Antipsychotic Sales by Country (K Units), 2027–2032
Table 43. Latin America Long-acting Antipsychotic Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Long-acting Antipsychotic Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Long-acting Antipsychotic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Long-acting Antipsychotic Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Long-acting Antipsychotic Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Long-acting Antipsychotic Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Long-acting Antipsychotic Revenue by Country (US$ Million), 2027–2032
Table 50. Global Long-acting Antipsychotic Sales (K Units) by Type (2021–2026)
Table 51. Global Long-acting Antipsychotic Sales (K Units) by Type (2027–2032)
Table 52. Global Long-acting Antipsychotic Sales Market Share by Type (2021–2026)
Table 53. Global Long-acting Antipsychotic Sales Market Share by Type (2027–2032)
Table 54. Global Long-acting Antipsychotic Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Long-acting Antipsychotic Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Long-acting Antipsychotic Revenue Market Share by Type (2021–2026)
Table 57. Global Long-acting Antipsychotic Revenue Market Share by Type (2027–2032)
Table 58. Global Long-acting Antipsychotic Price (US$/Unit) by Type (2021–2026)
Table 59. Global Long-acting Antipsychotic Price (US$/Unit) by Type (2027–2032)
Table 60. Global Long-acting Antipsychotic Sales (K Units) by Application (2021–2026)
Table 61. Global Long-acting Antipsychotic Sales (K Units) by Application (2027–2032)
Table 62. Global Long-acting Antipsychotic Sales Market Share by Application (2021–2026)
Table 63. Global Long-acting Antipsychotic Sales Market Share by Application (2027–2032)
Table 64. Global Long-acting Antipsychotic Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Long-acting Antipsychotic Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Long-acting Antipsychotic Revenue Market Share by Application (2021–2026)
Table 67. Global Long-acting Antipsychotic Revenue Market Share by Application (2027–2032)
Table 68. Global Long-acting Antipsychotic Price (US$/Unit) by Application (2021–2026)
Table 69. Global Long-acting Antipsychotic Price (US$/Unit) by Application (2027–2032)
Table 70. Oakwood Labs Company Information
Table 71. Oakwood Labs Description and Business Overview
Table 72. Oakwood Labs Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Oakwood Labs Long-acting Antipsychotic Product
Table 74. Oakwood Labs Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva Long-acting Antipsychotic Product
Table 79. Teva Recent Developments/Updates
Table 80. MedinCell Company Information
Table 81. MedinCell Description and Business Overview
Table 82. MedinCell Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. MedinCell Long-acting Antipsychotic Product
Table 84. MedinCell Recent Developments/Updates
Table 85. Janssen Company Information
Table 86. Janssen Description and Business Overview
Table 87. Janssen Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Janssen Long-acting Antipsychotic Product
Table 89. Janssen Recent Developments/Updates
Table 90. Otsuka America Pharmaceutical, Inc. Company Information
Table 91. Otsuka America Pharmaceutical, Inc. Description and Business Overview
Table 92. Otsuka America Pharmaceutical, Inc. Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Otsuka America Pharmaceutical, Inc. Long-acting Antipsychotic Product
Table 94. Otsuka America Pharmaceutical, Inc. Recent Developments/Updates
Table 95. Lundbeck Company Information
Table 96. Lundbeck Description and Business Overview
Table 97. Lundbeck Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Lundbeck Long-acting Antipsychotic Product
Table 99. Lundbeck Recent Developments/Updates
Table 100. Eli Lilly Company Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Eli Lilly Long-acting Antipsychotic Product
Table 104. Eli Lilly Recent Developments/Updates
Table 105. Alkermes Company Information
Table 106. Alkermes Description and Business Overview
Table 107. Alkermes Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Alkermes Long-acting Antipsychotic Product
Table 109. Alkermes Recent Developments/Updates
Table 110. Par Pharmaceutical Company Information
Table 111. Par Pharmaceutical Description and Business Overview
Table 112. Par Pharmaceutical Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Par Pharmaceutical Long-acting Antipsychotic Product
Table 114. Par Pharmaceutical Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. AbbVie Long-acting Antipsychotic Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Luye Pharmaceutical Company Information
Table 121. Luye Pharmaceutical Description and Business Overview
Table 122. Luye Pharmaceutical Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Luye Pharmaceutical Long-acting Antipsychotic Product
Table 124. Luye Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Long-acting Antipsychotic Distributors List
Table 128. Long-acting Antipsychotic Customers List
Table 129. Long-acting Antipsychotic Market Trends
Table 130. Long-acting Antipsychotic Market Drivers
Table 131. Long-acting Antipsychotic Market Challenges
Table 132. Long-acting Antipsychotic Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-acting Antipsychotic
Figure 2. Global Long-acting Antipsychotic Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Long-acting Antipsychotic Market Share by Type: 2025 & 2032
Figure 4. Aripiprazole Product Picture
Figure 5. Haloperidol Product Picture
Figure 6. Paliperidone Product Picture
Figure 7. Risperidone Product Picture
Figure 8. Olanzapine Product Picture
Figure 9. Others Product Picture
Figure 10. Global Long-acting Antipsychotic Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Long-acting Antipsychotic Market Share by Application: 2025 & 2032
Figure 12. Schizophrenia
Figure 13. Bipolar Disorder
Figure 14. Others
Figure 15. Global Long-acting Antipsychotic Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Long-acting Antipsychotic Market Size (US$ Million), 2021–2032
Figure 17. Global Long-acting Antipsychotic Sales (K Units), 2021–2032
Figure 18. Global Long-acting Antipsychotic Average Price (US$/Unit), 2021–2032
Figure 19. Long-acting Antipsychotic Report Years Considered
Figure 20. Long-acting Antipsychotic Sales Share by Manufacturers in 2025
Figure 21. Global Long-acting Antipsychotic Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Long-acting Antipsychotic Players: Market Share by Revenue in Long-acting Antipsychotic in 2025
Figure 23. Long-acting Antipsychotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Long-acting Antipsychotic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Long-acting Antipsychotic Sales Market Share by Country (2021–2032)
Figure 26. North America Long-acting Antipsychotic Revenue Market Share by Country (2021–2032)
Figure 27. United States Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Long-acting Antipsychotic Sales Market Share by Country (2021–2032)
Figure 30. Europe Long-acting Antipsychotic Revenue Market Share by Country (2021–2032)
Figure 31. Germany Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Long-acting Antipsychotic Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Long-acting Antipsychotic Revenue Market Share by Region (2021–2032)
Figure 38. China Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Long-acting Antipsychotic Sales Market Share by Country (2021–2032)
Figure 46. Latin America Long-acting Antipsychotic Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Long-acting Antipsychotic Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Long-acting Antipsychotic Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Long-acting Antipsychotic Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Long-acting Antipsychotic by Type (2021–2032)
Figure 57. Global Revenue Market Share of Long-acting Antipsychotic by Type (2021–2032)
Figure 58. Global Long-acting Antipsychotic Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Long-acting Antipsychotic by Application (2021–2032)
Figure 60. Global Revenue Market Share of Long-acting Antipsychotic by Application (2021–2032)
Figure 61. Global Long-acting Antipsychotic Price (US$/Unit) by Application (2021–2032)
Figure 62. Long-acting Antipsychotic Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
